Metabolic Genetic Testing Market Trends

Growth Drivers

• Increasing Prevalence of Metabolic Disease - In recent years it has been observed that the cases of diabetes have been increasing, and many countries might face a potential metabolic disorder epidemic. Many industrial countries are concerned with the chronic obesity epidemic, with the U.S. leading in the number of obese cases. The state of the global economy has improved over time, particularly in underdeveloped nations where there is a high prevalence of metabolic illnesses. Governments all across the world are being urged by researchers to take action and develop studies and solutions to reduce obesity and diabetes. In 2022, according to CDC estimates 37.3 million people have diabetes (11.3% of the US population). 96 million people aged 18 years or older have prediabetes (38.0% of the adult US population) and 26.4 million people aged 65 years or older (48.8%) have prediabetes.
• Rising Prevalence of Chronic Diseases - Increasing sedentary occupations, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world's population, especially non-communicable diseases such as diabetes and obesity. The main causes of metabolic disorders are long working hours, decreased physical activity, and unhealthy eating habits. According to the World Health Organization (WHO), the prevalence of chronic disease is expected to rise by over 57% globally, by the year 2020.
• Rapidly Aging Population - According to world bank population ages 65 and above was 10% of total population and it is expected to increase in coming years which will help t0 drive the global metabolic genetic testing market.
• Surge in the Cases of Smoking - In 2020, 22.3% of the global population used tobacco, which accounted for 36.7% of all men and 7.8% of the women across the world. Although certain LMICs (Low- and Middle-Income Countries) are seeing a decline in smoking prevalence, the developing world is expected to continue to see a rise in smoking-related illnesses and fatalities due to the relatively high population growth rate.
• Growing Healthcare Expenditure -According to world bank the globally current healthcare expenditure accounted for ~9.83% of GDP.

Challenges

• High Pricing of Some Medicines and Drugs
• Absence of Favorable Reimbursement Policies, Especially in Underdeveloped and Emerging Economies
• High Initial Cost of Technologically Advanced Software Solutions and Equipment

The rise in the prevalence of genetic metabolic disorders, changes in lifestyle, technological developments in screening methods, public awareness of genetic testing, and increased research and development are additional factors contributing to the growth of the global market for metabolic, genetic testing. In DNA sequencing, numerous technological developments are taking place. There are currently countless hereditary metabolic diseases. Lysosomal storage diseases, mitochondrial disorders, disorders of metal metabolism, solar sensitivity, thyroid disease, etc., are a few of them. In April 2019, Centogene N.V launched a panel for detection of rare metabolic disease, combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions.